Skip to Content
MilliporeSigma
All Photos(1)

Documents

BP802

Lamivudine

British Pharmacopoeia (BP) Reference Standard

Synonym(s):

2′,3′-Dideoxy-3′-thiacytidine, 3TC, Epivir, Epivir-HBV, Heptovir, Zeffix

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C8H11N3O3S
CAS Number:
134678-17-4
Molecular Weight:
229.26
MDL number:
MFCD00869739
UNSPSC Code:
41116107
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

lamivudine

form

solid

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

BP

application(s)

pharmaceutical
pharmaceutical small molecule

format

neat

storage temp.

2-8°C

SMILES string

NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2

InChI

1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1

InChI key

JTEGQNOMFQHVDC-NKWVEPMBSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Lamivudine BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Abacavir, Zidovudine and Lamivudine Tablets
  • Zidovudine and Lamivudine Tablets
  • Abacavir and Lamivudine Tablets
  • Lamivudine Tablets

    • Biochem/physiol Actions

    Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor (nRTI). It is an analogue of cytidine, and can inhibit both types (1 and 2) of HIV reverse transcriptase as well as the reverse transcriptase of hepatitis B. It needs to be phosphorylated to its triphosphate form before it is active. 3TC-triphosphate also inhibits cellular DNA polymerase.

    Packaging

    Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

    Other Notes

    Sales restrictions may apply.

    related product

    Product No.
    Description
    Pricing

    1356836

    Lamivudine, United States Pharmacopeia (USP) Reference Standard

    PHR1365

    Lamivudine, Pharmaceutical Secondary Standard; Certified Reference Material

    Y0000425

    Lamivudine, European Pharmacopoeia (EP) Reference Standard

    Y0000426

    Lamivudine for system suitability 2, European Pharmacopoeia (EP) Reference Standard

    Y0000518

    Lamivudine for system suitability 1, European Pharmacopoeia (EP) Reference Standard

    BP857

    Lamivudine impurity standard, British Pharmacopoeia (BP) Reference Standard

    BP850

    Zidovudine and Lamivudine impurity standard, British Pharmacopoeia (BP) Reference Standard

    PHR8938

    Lamivudine (R)-Sulfoxide, Pharmaceutical Secondary Standard; Certified Reference Material

    pictograms

    Health hazard
    GHS08

    signalword

    Warning

    hcodes

    H361

    pcodes

    P280

    Hazard Classifications

    Repr. 2

    wgk_germany

    WGK 3

    flash_point_f

    Not applicable

    flash_point_c

    Not applicable

    Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    Sorry, we don't have COAs for this product available online at this time.

    If you need assistance, please contact Customer Support.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service